135 results on '"Toffolatti, Luisa"'
Search Results
2. Assessing suffering of patients on cancer treatment and of those no longer treated using ESAS–Total Care (TC)
3. Case report: pseudoendocrine sarcoma, a clinicopathologic report of a newly described soft tissue neoplasm
4. Italian version of the Edmonton Symptom Assessment System (ESAS)–Total Care (TC): development and psychometric validation in patients undergoing cancer treatment or follow-up
5. Clear cell sarcoma-like/malignant gastrointestinal neuroectodermal tumor of the tongue: a clinicopathologic and molecular case report
6. The validation of the Italian version of the COmprehensive Score for financial Toxicity (COST)
7. Case report: pseudoendocrine sarcoma, a clinicopathologic report of a newly described soft tissue neoplasm.
8. Italian version of the Edmonton Symptom Assessment System (ESAS)–Total Care (TC): development and psychometric validation in patients undergoing cancer treatment or follow-up
9. Tempo and Mode of Evolution of a Primate-Specific Retrotransposon Belonging to the LINE 1 Family
10. Analysis of 22 deletion breakpoints in dystrophin intron 49
11. Primary malignant ossifying fibromyxoid tumour of the bone. A clinicopathologic and molecular report of two cases
12. Clear cell sarcoma-like/malignant gastrointestinal neuroectodermal tumor of the tongue: a clinicopathologic and molecular case report
13. Multifocal Medulloblastoma in an Adult Patient: Description of a Rare Presentation and Review of the Literature
14. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours
15. Phase I study of escalating doses of oxaliplatin in combination with fixed dose gemcitabine in patients with non-small cell lung cancer
16. A clinical pharmacogenetic characterization of DPD polymorphisms for pre-treatment screening of patients candidates to fluoropyrimidine therapy
17. Intervening Sequences in Paralogous Genes: A Comparative Genomic Approach to Study the Evolution of X Chromosome Introns
18. CAPECITABINE IN COMBINATION WITH RADIOTHERAPY IN RECTAL CANCER AFTER CURATIVE SURGERY
19. Phase II trial of pemetrexed disodium administered every 21 days in patients (pts) with gastric cancer: Efficacy and toxicity without and with folic acid.
20. OPTIMAL END OF LIFE CARE
21. Investigating the Mechanism of Chromosomal Deletion: Characterization of 39 Deletion Breakpoints in Introns 47 and 48 of the Human Dystrophin Gene
22. Steroidal aromatase inhibitors in elderly patients
23. The luteinising hormone–releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers
24. Concomitant Amplif ication and Expression of PAX7-FKHR and MYCN in a Human Rhabdomyosarcoma Cell Line Carrying a Cryptic t(1;13)(p36;q14)
25. Interferon-Gamma and Tumor Necrosis Factor-Related Weak Inducer of Apoptosis Expression in Neoangiogenesis in Colorectal Polypoid Lesions
26. Interferon-Gamma and Tumor Necrosis Factor-Related Weak Inducer of Apoptosis Expression in Neoangiogenesis in Colorectal Polypoid Lesions.
27. Su1790 - Role of IFN-Gamma and Tweak Expression in Neoangiogenesis in Colorectal Polypoid Lesions
28. Clinicopathological Features of C11orf95-RELA Positive Ependymomas in a Series of Adult and Young Patients with Long Follow-Up
29. Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories
30. Colorectal polypoid lesions and expression of vascular endothelial growth factor in a consecutive series of endoscopic and surgical patients
31. IN9 - OPTIMAL END OF LIFE CARE
32. KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST
33. Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal Tumor
34. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors
35. Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis–Associated GI Stromal Tumor
36. KIT, PDGFRA, and BRAF Mutational Spectrum Impacts on the Natural History of Imatinib-naive Localized GIST
37. Audiological Phenotype of patients showing connexin 26/30 related deafness in a cohort including 628 patients
38. Synchronous sporadic gastrointestinal stromal tumors (GISTs) of the colon
39. A novel missense mutation in the Connexin 26 gene associated with autosomal recessive nonsyndromic sensorineural hearing loss in a consanguineous Tunisian family
40. Impact of Molecular Analysis on the Final Sarcoma Diagnosis
41. Impact of IVS14+1G>A and 2846A>T DPYD polymorphisms on toxicity outcome of patients treated with fluoropyrimidine-containing regimens.
42. Natural History of Imatinib-naive GISTs
43. Molecular and Clinicopathologic Characterization of Gastrointestinal Stromal Tumors (GISTs) of Small Size
44. Efficacy of Treatment with Irinotecan and Oxaliplatin Combination in FU-Resistant Metastatic Colorectal Cancer Patients
45. Genomic definition of a pure intronic dystrophin deletion responsible for an XLDC splicing mutation: in vitro mimicking and antisense modulation of the splicing abnormality
46. MYCN expression in human rhabdomyosarcoma cell lines and tumour samples
47. Ovarian Ablation for Premenopausal Early-Stage Breast Cancer: An Update
48. Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study11Data management by Italian Trials in Medical Oncology (I.T.M.O.) Scientific Service.
49. Normal and Rearranged PAX3 Expression in Human Rhabdomyosarcoma
50. MYCNexpression in human rhabdomyosarcoma cell lines and tumour samples
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.